(Q41306010)

29 September 2017

title

Fluoroquinolones in animal health (English)

1 reference

29 September 2017

Brown SA

1

1 reference

29 September 2017

publication date

1 February 1996

1 reference

Journal of Veterinary Pharmacology and Therapeutics

29 September 2017

published in

1 reference

29 September 2017

volume

19

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

1-14

1 reference

Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Use of quinolones for treatment of ear and eye infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

An evaluation of pelvic tissue concentrations after oral administration of enoxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Effect of norfloxacin on theophylline pharmacokinetics at steady state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Treatment of experimental Salmonella typhimurium infection in mice with lomefloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Routes of quinolone permeation in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Bactericidal activity and killing rate of serum in volunteers receiving pefloxacin alone or in combination with ceftazidime, piperacillin or mezlocillin against Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Levels of rifampin and ciprofloxacin in nasal secretions: correlation with MIC90 and eradication of nasopharyngeal carriage of bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Pharmacokinetics of ciprofloxacin in ponies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Dose ranging study and constant infusion evaluation of ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Mode of action, and in vitro and in vivo activities of the fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Ciprofloxacin pharmacokinetics after a standard or high-fat/high-calcium breakfast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Newly documented antimicrobial activity of quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Pharmacokinetics of three newer quinolones in pregnant and lactating women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Placement of alkyl substituents on the C-7 piperazine ring of fluoroquinolones: dramatic differential effects on mammalian topoisomerase II and DNA gyrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Inhibition of enoxacin absorption by antacids or ranitidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Antibacterial activity of ciprofloxacin in conventional tests and in a model of bacterial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Mode of action of the new quinolones: New data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Recovery of pefloxacin in saliva and feces and its action on oral and fecal floras of healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Factors influencing the uptake of norfloxacin by Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

The effect of ciprofloxacin on antipyrine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Influence of LY146032 on human polymorphonuclear leucocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Synergy and antagonism of combinations with quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Side-effects of quinolones: Comparisons between quinolones and other antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Mechanisms of resistance to quinolones and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

New quinolones and gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Intestinal elimination of ciprofloxacin in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

The activity of ciprofloxacin and other 4-quinolones againstChlamydia trachomatis andMycoplasmas in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Immunological aspects of new quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Mutational resistance to 4-quinolone antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Effect of lactation on single-dose pharmacokinetics of norfloxacin nicotinate in ewes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Activity of temafloxacin against respiratory pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

In vitro activities of amifloxacin and two of its metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

Pharmacokinetics of quinolones: Newer aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1996.TB00001.X

10.1111/J.1365-2885.1996.TB00001.X

21 January 2018

Identifiers

DOI

1 reference

29 September 2017

1 reference